Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Knight Diagnostic Laboratories, |
RCV003330334 | SCV003852623 | likely pathogenic | Stickler syndrome type 2 | 2021-08-05 | criteria provided, single submitter | clinical testing | To our knowledge, the missense variant c.3512G>A (p.Gly1171Asp) in COL11A1 has not been reported in an affected individual. This variant was not detected in a large population database (gnomAD). This variant is located in a triple helical region of this protein and occurs in an important glycine residue of the Gly-X-Y repeat motif that is essential for the formation of the helix and for normal protein folding in collagens (Shoulders and Raines 2009). In a study looking at the effects of missense mutations reported in osteogenesis imperfecta cases that occur in the Gly residue of this motif in collagen genes of a related collagen protein (type I), it was found that Asp was the most destabilizing substitution. However, there are other factors such as location of the motif that may also have an effect (Beck et al. 2000). In further evidence of the importance of the glycine residue in this region, all ClinVar reported pathogenic or likely pathogenic missense variants in this gene occur in glycine residues in this triple helical region with 5/13 being Asp substitutions (ClinVar). There have also been additional reported missense variants that occur in the Gly residue in this motif in COL11A1 in affected individuals (Kohmoto et al. 2016). However, there are also missense variants in glycine residues in this region that have been classified as uncertain significance (ClinVar). Consensus of computational algorithms are damaging for this variant (SIFT=0.0, Polyphen=1, CADD=22.500, GERP=5.72). This variant has been shown to segregate with disease in several affected family members (KDL internal data). In summary, this variant meets our criteria for likely pathogenic. |